Pharmacological treatment with dimethyl amiloride (DMA) decreases CAFs’ sEV secretion, reduces TGF‐β signalling levels in tumour cells and abrogates metastasis and tumour self‐seeding. The gene discussed is TGFB1; the disease is neoplasm.